These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18524993)

  • 1. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
    Sallmyr A; Tomkinson AE; Rassool FV
    Blood; 2008 Aug; 112(4):1413-23. PubMed ID: 18524993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL stimulates WRN to promote survival and genomic instability.
    Slupianek A; Poplawski T; Jozwiakowski SK; Cramer K; Pytel D; Stoczynska E; Nowicki MO; Blasiak J; Skorski T
    Cancer Res; 2011 Feb; 71(3):842-51. PubMed ID: 21123451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
    Tobin LA; Robert C; Rapoport AP; Gojo I; Baer MR; Tomkinson AE; Rassool FV
    Oncogene; 2013 Apr; 32(14):1784-93. PubMed ID: 22641215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy.
    Fan J; Li L; Small D; Rassool F
    Blood; 2010 Dec; 116(24):5298-305. PubMed ID: 20807885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing.
    Kusumoto R; Dawut L; Marchetti C; Wan Lee J; Vindigni A; Ramsden D; Bohr VA
    Biochemistry; 2008 Jul; 47(28):7548-56. PubMed ID: 18558713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
    Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
    Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting FEN1 Suppresses the Proliferation of Chronic Myeloid Leukemia Cells Through Regulating Alternative End-Joining Pathways.
    Zhu Y; Dai H; Wang Y; Liang Y; Feng W; Yuan Y
    DNA Cell Biol; 2021 Aug; 40(8):1101-1111. PubMed ID: 34156283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway.
    Della-Maria J; Zhou Y; Tsai MS; Kuhnlein J; Carney JP; Paull TT; Tomkinson AE
    J Biol Chem; 2011 Sep; 286(39):33845-53. PubMed ID: 21816818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the DNA ligases encoded by the mammalian LIG3 gene.
    Tomkinson AE; Sallmyr A
    Gene; 2013 Dec; 531(2):150-7. PubMed ID: 24013086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for Artemis nuclease in the repair of radiation-induced DNA double strand breaks by alternative end joining.
    Moscariello M; Wieloch R; Kurosawa A; Li F; Adachi N; Mladenov E; Iliakis G
    DNA Repair (Amst); 2015 Jul; 31():29-40. PubMed ID: 25973742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ligase IV and artemis act cooperatively to suppress homologous recombination in human cells: implications for DNA double-strand break repair.
    Kurosawa A; Saito S; So S; Hashimoto M; Iwabuchi K; Watabe H; Adachi N
    PLoS One; 2013; 8(8):e72253. PubMed ID: 23967291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks.
    Liang L; Deng L; Nguyen SC; Zhao X; Maulion CD; Shao C; Tischfield JA
    Nucleic Acids Res; 2008 Jun; 36(10):3297-310. PubMed ID: 18440984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.
    Yuan M; Wang Y; Qin M; Zhao X; Chen X; Li D; Miao Y; Otieno Odhiambo W; Liu H; Ma Y; Ji Y
    Cancer Sci; 2021 Jul; 112(7):2679-2691. PubMed ID: 33949040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining.
    Soni A; Siemann M; Grabos M; Murmann T; Pantelias GE; Iliakis G
    Nucleic Acids Res; 2014 Jun; 42(10):6380-92. PubMed ID: 24748665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.
    Arora S; Yan H; Cho I; Fan HY; Luo B; Gai X; Bodian DL; Vockley JG; Zhou Y; Handorf EA; Egleston BL; Andrake MD; Nicolas E; Serebriiskii IG; Yen TJ; Hall MJ; Golemis EA; Enders GH
    Gastroenterology; 2015 Dec; 149(7):1872-1883.e9. PubMed ID: 26344056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.
    Sallmyr A; Fan J; Rassool FV
    Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway.
    Aggarwal M; Banerjee T; Sommers JA; Iannascoli C; Pichierri P; Shoemaker RH; Brosh RM
    Cancer Res; 2013 Sep; 73(17):5497-507. PubMed ID: 23867477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
    Poplawski T; Blasiak J
    Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbed replication induced genome wide or at common fragile sites is differently managed in the absence of WRN.
    Murfuni I; De Santis A; Federico M; Bignami M; Pichierri P; Franchitto A
    Carcinogenesis; 2012 Sep; 33(9):1655-63. PubMed ID: 22689923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.